Cryo-Cell has recently announced research partnership with the National Institutes of Health in researching the potential treatment of breast cancer using stem cells collected from menstrual blood.

There is exciting news in the world of breast cancer research as Cryo-Cell International Inc., America’s most established cord blood bank, and the National Institutes of Health (NIH) Clinical Center have just announced a research partnership . Through this partnership they will conduct an exploratory study to determine if stem cells collected from menstrual blood can be used in the potential treatment of breast cancer and treating diseases.  This study will include cutting-edge techniques making it possible to track stems cells in the body using magnetic resonance imaging(MRI)—a non-invasive method. Currently, non-invasive imaging for long term tracking of stem cells in the body do not yet exist, making this truly ground breaking research. The ability to use MRI to monitor the journey of menstrual blood stem cells in the body holds great promise in the utilization of menstrual stem cells in the future treatment of disease. Cryo-Cell’s research partnership with the NIH is a major step towards discovering potential breast cancer therapy.

With a commitment to superior service, Cryo-Cell is committed to serving the needs of parents, with highly trained child birth educators available for consultation 24 hours a day, 7 days a week. Cryo-Cell has successfully stored more than 160,000 cord blood samples.

This entry was posted on Tuesday, December 9th, 2008 at 12:18 am and is filed under ppp. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.